Simultaneous Lengthening of Bilateral Femora and Tibiae in Achondroplastic Patients

The purpose of this study is to determine whether lengthening of both the tibiae and femora in achondroplastic patients is safe and provides reproducible outcome.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

SHOX Gene With Short Stature Bone Diseases Bone Diseases, Developmental Congenital, Hereditary, and Neonatal Diseases and Abnormalities Dwarfism Endocrine System Diseases Genetic Diseases, Inborn Musculoskeletal Diseases

Age range

3 year–11 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Istanbul Medical School

Istanbul, 34390, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Achondroplasia, first lengthening period

Exclusion criteria

Previous lengthening

Treatment and study plan

Lengthening over nail

Procedure

External fixator is used to lengthen either the femur or the tibia over an intramedullary nail

Primary outcomes

Paley's functional scoring system

Time frame: Minimum 2 year follow-up

Paley's functional scoring system evaluates the results after lengthening or deformity correction procedures: residual limb length discrepancy, any brace or other aid usage, joint contracture, pain, soft tissue dystrophism

Sponsors and collaborators

Lead sponsor

Bilen, Fikri Erkal, M.D.

Indiv

Registry information

Important dates

Study start: 2002
Primary completion: 2008
Study completion: 2011
First posted: Apr 4, 2011
Registry last updated: Apr 4, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed